[August 29, 2016] |
|
Stimwave's Drug-Free Wireless Pain Relief Neurostimulator Changing the Lives of People Suffering From Chronic Pain
Stimwave LLC, a medical device manufacturer and independent research
institute headquartered in South Florida, has achieved long-term success
for hundreds of pain patients during the early adaptor rollout of the
world's first miniature wireless pain relief system. Embraced by pain
specialists seeking non-opioid treatments, the drug-free, breakthrough
remedy offers new hope to the more than 400 million people worldwide who
suffer from chronic pain.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160829005845/en/
(Photo: Stimwave Technologies Incorporated)
"Every day in the U.S. an average of 120 people die as a result of drug
overdose, more than from motor vehicle crashes, and another 6,700-plus
are treated in emergency departments for the misuse or abuse of
prescription pain medication," said Stimwave Chairman and CEO Laura
Tyler Perryman. "We believe that Stimwave's Wireless Pain Relief®
technology is not only a viable option to help millions of people who
suffer from chronic pain, but a potential life-saver as the U.S. faces
an epidemic of opioid addiction that in many cases is an unavoidable
side effect of long-term use of addictive pain medication."
Stimwave's Wireless Pain Relief devices are 95 percent smaller than any
other neuromodulation device on the market, so small, with a diameter of
less than 1.5 millimeters, that they are simply implanted through a
standard needle during an outpatient procedure and a minimally invasive
receiver placement technique. Because they are wireless, with the power
source discreetly worn outside the body, there is no need for the
invasive "open surgery" required of earlier neuromodulation devices,
reducing the risk of infection, pain at the site of a large battery, and
other long-term complications of battery units and connectors that
account for 85 percent of adverse events, according to registries.
Futher, this miniature wireless device is powered by a wearable
antenna, easily integrated into clothing and requiring no sticky gels
that could irritate the skin, and there are no "wires" protruding from
the body.
"This is great news for pain specialists and chronic pain patients who
previously did not have a minimally-invasive implant option available
for pain," said Dr. Sanjay Gupta, president of the American Pain
Association and principal clinician at Atlantic Pain and Wellness
Institute. "Our country is facing a horrible epidemic of drug overdose
deaths. These wireless products provide an alternative to opioids, which
is much needed in the armamentarium for effective pain control."
Stimwave launched it's FDA-cleared devices for the relief of chronic
back and leg pain to a limited number of patients throughout 2015, and
in March 2016 was granted FDA 510(k) for the relief of peripheral
nervous system (PNS) pain, becoming the only neuromodulation device
manufacturer cleared by the FDA to help reduce chronic neuropathic pain
at most locations throughout the body, from back and leg pain addressed
by spinal cord stimulation to PNS treatment for shoulder pain, wrist and
elbow pain, knee pain, hip pain and more.
"The major issue with peripheral nerve stimulators in the past has
always been the bulk and length of cables, connectors and pulse
generators," said Dr. Richard North, consultant and retired Professor of
Neurosurgery at John Hopkins University School of Medicine. "A miniature
wireless peripheral nerve stimulator will minimize the need for surgery
in patients who already are suffering from pain. It has long been needed
and now is finally a reality."
Stimwave's wireless device delivers small pulses of energy to specific
nerves, triggering a reaction that enables the brain to remap pain
pathways, thus providing pain relief. The Stimwave device contains no
internal batteries or other toxic materials. The device is fixed in
place by an anchor, so it stays "in line" with the body's nerves,
allowing a freedom of motion that is impossible with bulkier implanted
devices.
The Stimwave portfolio also includes the only neuromodulation system
approved for "full body" MRI examinations, meaning the device does not
have to be removed for 3-Tesla MRI exams. This is a significant
diagnostic breakthrough as it allows patients with pain to benefit from
neuromodulation without restricting their access to MRI-assisted
diagnoses, for current or future medical issues.
"Stimwave saved my life. Without this amazing product, I would still be
in terrible pain, on medication, and having my health fail," said
Anthony Torres, a cargo crane operator severely injured in an industrial
accident. [Please see accompanying Patient
Profiles.] "The external wireless batteries are small,
effective, and simple-to-use.
"The best thing about Stimwave is that it gave me relief from the pain
and allowed me to get off the pain medications. I wanted to get off all
the pain medications."
Please visit www.stimwave.com
for more information.
About Stimwave
Stimwave Technologies Incorporated is a privately held medical device
company engaged in the development, manufacture, and commercialization
of wirelessly powered, microtechnology neurostimulators, providing
patients with a convenient, safe, minimally invasive, and highly
cost-effective pain management solution that is easily incorporated into
their daily lives. Stimwave's goal is to evolve its patented,
cutting-edge platform into the default for neuromodulation, increasing
the accessibility for patients worldwide while lowering the economic
impact of pain management.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160829005845/en/
[ Back To Mobile World Congress's Homepage ]
|